• Introduction
• Company Profile
• Science and Technology
• Business
  • Intellectual Property
  • Business Development
  • Investment Opportunity
  • Contact

Intellectual Property

Harbour Antibodies holds an exclusive global license to a growing patent portfolio comprising:

• derivation of H2L2 and HCAbs in transgenic animals in response to antigen challenge
• VH domain antibody complexes

Harbour Antibodies has  granted patents, and further patent applications are being prosecuted in all major markets

Harbour Antibodies employs experienced, specialist patent attorneys  in the UK and USA to protect its interests